| 标题 |
Impact of treatment with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB
替诺福韦艾拉酚胺（TAF）或富马酸替诺福韦二吡呋酯（TDF）治疗对慢性乙型肝炎患者肝细胞癌（HCC）发病率的影响
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
] Lim Y-S, Chan HLY, Seto W-K, Ning Q, Agarwal K, Janssen HLA, et al., editors. Impact of treatment with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB). AASLD Liver Meeting 2019; 2019. |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
SYLH
冰魂
cdercder
nozero
卡卡西
非而者厚
失眠醉易
昏睡的蟠桃
LMNg6n
科研助手6
iNk
蛇虫鼠蚁
蓝调爱科研
子车茗
Accepted
ZhouYW
故酒
粗心的绾绾
善良的剑通
pcr163
皖公网安备34019202002308
